OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2022
(2)
2018
(2)
2023
(1)
2021
(1)
2019
(1)
2015
(1)
2006
(1)
1999
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficient tracing of global isolates of Yersinia pestis by restriction fragment length polymorphism analysis using three insertion sequences as probes.
Not available
S-EPMC1489393
|
biostudies-literature
Cite
Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis.
Not available
S-EPMC24187
|
biostudies-literature
Cite
Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.
Not available
S-EPMC5849801
|
biostudies-literature
Cite
Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations.
Not available
S-EPMC6113491
|
biostudies-literature
Cite
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.
Not available
S-EPMC6694172
|
biostudies-literature
Cite
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
Not available
S-EPMC4695163
|
biostudies-literature
Cite
In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis.
Not available
S-EPMC10484791
|
biostudies-literature
Cite
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century.
Not available
S-EPMC8802117
|
biostudies-literature
Cite
Effectiveness of GenoType MTBDR<i>sl</i> in excluding TB drug resistance in a clinical trial.
Not available
S-EPMC7614701
|
biostudies-literature
Cite
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Not available
S-EPMC7614824
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets